Cargando…

DPV-001 an autophagosome-enriched cancer vaccine in phase II clinical trials contains 25 putative cancer antigens, DAMPS, HSPS and agonists for TLR 2, 3, 4, 7 and 9

Detalles Bibliográficos
Autores principales: Hilton, Traci L, Hulett, Tyler W, Dubay, Chistopher, van de Ven, Rieneke, Aung, Sandra, Urba, Walter J, Hu, Hong Ming, Fox, Bernard A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991108/
http://dx.doi.org/10.1186/2051-1426-1-S1-P260
_version_ 1782312384567705600
author Hilton, Traci L
Hulett, Tyler W
Dubay, Chistopher
van de Ven, Rieneke
Aung, Sandra
Urba, Walter J
Hu, Hong Ming
Fox, Bernard A
author_facet Hilton, Traci L
Hulett, Tyler W
Dubay, Chistopher
van de Ven, Rieneke
Aung, Sandra
Urba, Walter J
Hu, Hong Ming
Fox, Bernard A
author_sort Hilton, Traci L
collection PubMed
description
format Online
Article
Text
id pubmed-3991108
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39911082014-05-01 DPV-001 an autophagosome-enriched cancer vaccine in phase II clinical trials contains 25 putative cancer antigens, DAMPS, HSPS and agonists for TLR 2, 3, 4, 7 and 9 Hilton, Traci L Hulett, Tyler W Dubay, Chistopher van de Ven, Rieneke Aung, Sandra Urba, Walter J Hu, Hong Ming Fox, Bernard A J Immunother Cancer Poster Presentation BioMed Central 2013-11-07 /pmc/articles/PMC3991108/ http://dx.doi.org/10.1186/2051-1426-1-S1-P260 Text en Copyright © 2013 Hilton et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Hilton, Traci L
Hulett, Tyler W
Dubay, Chistopher
van de Ven, Rieneke
Aung, Sandra
Urba, Walter J
Hu, Hong Ming
Fox, Bernard A
DPV-001 an autophagosome-enriched cancer vaccine in phase II clinical trials contains 25 putative cancer antigens, DAMPS, HSPS and agonists for TLR 2, 3, 4, 7 and 9
title DPV-001 an autophagosome-enriched cancer vaccine in phase II clinical trials contains 25 putative cancer antigens, DAMPS, HSPS and agonists for TLR 2, 3, 4, 7 and 9
title_full DPV-001 an autophagosome-enriched cancer vaccine in phase II clinical trials contains 25 putative cancer antigens, DAMPS, HSPS and agonists for TLR 2, 3, 4, 7 and 9
title_fullStr DPV-001 an autophagosome-enriched cancer vaccine in phase II clinical trials contains 25 putative cancer antigens, DAMPS, HSPS and agonists for TLR 2, 3, 4, 7 and 9
title_full_unstemmed DPV-001 an autophagosome-enriched cancer vaccine in phase II clinical trials contains 25 putative cancer antigens, DAMPS, HSPS and agonists for TLR 2, 3, 4, 7 and 9
title_short DPV-001 an autophagosome-enriched cancer vaccine in phase II clinical trials contains 25 putative cancer antigens, DAMPS, HSPS and agonists for TLR 2, 3, 4, 7 and 9
title_sort dpv-001 an autophagosome-enriched cancer vaccine in phase ii clinical trials contains 25 putative cancer antigens, damps, hsps and agonists for tlr 2, 3, 4, 7 and 9
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991108/
http://dx.doi.org/10.1186/2051-1426-1-S1-P260
work_keys_str_mv AT hiltontracil dpv001anautophagosomeenrichedcancervaccineinphaseiiclinicaltrialscontains25putativecancerantigensdampshspsandagonistsfortlr2347and9
AT huletttylerw dpv001anautophagosomeenrichedcancervaccineinphaseiiclinicaltrialscontains25putativecancerantigensdampshspsandagonistsfortlr2347and9
AT dubaychistopher dpv001anautophagosomeenrichedcancervaccineinphaseiiclinicaltrialscontains25putativecancerantigensdampshspsandagonistsfortlr2347and9
AT vandevenrieneke dpv001anautophagosomeenrichedcancervaccineinphaseiiclinicaltrialscontains25putativecancerantigensdampshspsandagonistsfortlr2347and9
AT aungsandra dpv001anautophagosomeenrichedcancervaccineinphaseiiclinicaltrialscontains25putativecancerantigensdampshspsandagonistsfortlr2347and9
AT urbawalterj dpv001anautophagosomeenrichedcancervaccineinphaseiiclinicaltrialscontains25putativecancerantigensdampshspsandagonistsfortlr2347and9
AT huhongming dpv001anautophagosomeenrichedcancervaccineinphaseiiclinicaltrialscontains25putativecancerantigensdampshspsandagonistsfortlr2347and9
AT foxbernarda dpv001anautophagosomeenrichedcancervaccineinphaseiiclinicaltrialscontains25putativecancerantigensdampshspsandagonistsfortlr2347and9